| AA | amino acid(s) |
| AA-Ac | acetylated amino acids |
| AIFM2 | apoptosis-inducing factor mitochondria associated 2 |
| ATF4 | activating transcription factor 4 |
| ATP | adenosine triphosphate |
| cAMP | N6,2′-O-dibutyryladenosine 3′,5′-cyclic monophosphate |
| DEG | differentially expressed gene |
| DGE | differential gene expression |
| ETC | electron transport chain |
| GDNF | glial-derived neurotrophic factor |
| GSEA/MSEA | gene/metabolite set enrichment analysis |
| GSH | reduced glutathione |
| MG | proteasome inhibitor MG-132 |
| NAD(H) | nicotinamide adenine dinucleotide (NAD+: oxidized, NADH: reduced) |
| NAT | N-terminal acetyltransferases |
| NRF2 | NFE2-like BZIP transcription factor 2 (NFE2L2) |
| ORA | overrepresentation analysis |
| PCA | principal component analysis |
| PD | Parkinson’s disease |
| Q | ubiquinone or coenzyme Q |
| ROS | reactive oxygen species |
| TCA | citric acid cycle or Krebs cycle or tricarboxylic acid cycle |
| TF | transcription factor(s) |
| Ubi | ubiquitin |
| Ubi-Prot | ubiquitinated protein(s) |